de Walle Hermien E K, de Jong-van den Berg Lolkje T W
Department of Medical Genetics, University Medical Centre Groningen, University of Groningen, Postbus 30001, 9700 RB, Groningen, The Netherlands.
Eur J Clin Pharmacol. 2008 May;64(5):539-43. doi: 10.1007/s00228-007-0446-6. Epub 2008 Jan 22.
Folic acid use in the periconceptional period reduces the risk of neural tube defects (NTDs). However, applying this knowledge in daily practice is not an easy task. We report here the current level of folic acid use in the Netherlands and discuss the figures within the framework of a national governmental campaign held in 1995 promoting the use of folic acid and the professional interventions undertaken since then.
We carried out six studies in the northern Netherlands during 1995, 1996, 1998, 2000, 2003 and 2005, respectively. The same methodology in the same health professionals' practices was followed in all studies. Pregnant women attending their first or second antenatal visit were asked to fill in a questionnaire aimed at assessing their awareness and use of folic acid.
In 2005, most of the pregnant women used folic acid "at some time in their pregnancy", and 51% used it for the entire advised period. Prior knowledge on the protective affect of folic acid and on the period of use was strongly related to the level of education. The use of folic acid in a previous pregnancy [odds ratio (OR) 3.9, 95% confidence interval (95% CI) 1.6-9.9], the use of an oral contraceptive (OR 2.1, 95% CI 1.1-4.1) and parity (OR 0.08, 95% CI 0.01-0.5) significantly predicted the current correct use. The most recent figures revealed that there is still a large gap between more highly and less educated women in terms of taking folic acid in the advised period: 63 versus 31%, respectively.
The aim of the Dutch Ministry of Health is to have 70% of Dutch women wanting to become pregnant use folic acid supplements in the advised period by 2010. While this level has almost been reached among more highly educated women (63%), it will take a great deal more effort, money and creativity to achieve the necessary increase from the current level of 31% among women with a lower educational background.
孕期使用叶酸可降低神经管缺陷(NTDs)的风险。然而,将这一知识应用于日常实践并非易事。我们在此报告荷兰目前叶酸的使用情况,并在1995年开展的全国性政府宣传活动框架内讨论这些数据,该活动旨在推广叶酸的使用以及此后采取的专业干预措施。
我们分别于1995年、1996年、1998年、2000年、2003年和2005年在荷兰北部进行了六项研究。所有研究均采用相同的方法,在相同的医疗专业人员诊所进行。要求前来进行首次或第二次产前检查的孕妇填写一份问卷,以评估她们对叶酸的知晓情况和使用情况。
2005年,大多数孕妇“在孕期的某个时候”使用了叶酸,51%的孕妇在建议的整个时间段内使用了叶酸。对叶酸保护作用及使用时间段的先验知识与教育程度密切相关。既往妊娠时使用叶酸(比值比[OR] 3.9,95%置信区间[95%CI] 1.6 - 9.9)、使用口服避孕药(OR 2.1,95%CI 1.1 - 4.1)和产次(OR 0.08,95%CI 0.01 - 0.5)显著预测当前的正确使用情况。最新数据显示,在建议时间段内服用叶酸方面,受教育程度较高和较低的女性之间仍存在很大差距:分别为63%和31%。
荷兰卫生部的目标是到2010年,让70%想要怀孕的荷兰女性在建议时间段内使用叶酸补充剂。虽然在受教育程度较高的女性中这一比例已接近达到(63%),但要使教育背景较低的女性从目前的31%提高到所需水平,还需要付出更多努力以及投入更多资金和创新举措。